Correlation Between Enliven Therapeutics and Sutro Biopharma
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Sutro Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Sutro Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Sutro Biopharma, you can compare the effects of market volatilities on Enliven Therapeutics and Sutro Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Sutro Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Sutro Biopharma.
Diversification Opportunities for Enliven Therapeutics and Sutro Biopharma
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Sutro is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Sutro Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sutro Biopharma and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Sutro Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sutro Biopharma has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Sutro Biopharma go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Sutro Biopharma
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.53 times more return on investment than Sutro Biopharma. However, Enliven Therapeutics is 1.89 times less risky than Sutro Biopharma. It trades about -0.18 of its potential returns per unit of risk. Sutro Biopharma is currently generating about -0.21 per unit of risk. If you would invest 2,763 in Enliven Therapeutics on September 2, 2024 and sell it today you would lose (325.00) from holding Enliven Therapeutics or give up 11.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Sutro Biopharma
Performance |
| Timeline |
| Enliven Therapeutics |
| Sutro Biopharma |
Enliven Therapeutics and Sutro Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Sutro Biopharma
The main advantage of trading using opposite Enliven Therapeutics and Sutro Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Sutro Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sutro Biopharma will offset losses from the drop in Sutro Biopharma's long position.| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
| Sutro Biopharma vs. Tff Pharmaceuticals | Sutro Biopharma vs. Eliem Therapeutics | Sutro Biopharma vs. Inhibrx | Sutro Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |